Protein kinase CK2: a challenge to canons

被引:392
|
作者
Pinna, LA
机构
[1] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy
[2] Venetian Inst Mol Med, I-23129 Padua, Italy
关键词
protein kinase; casein kinase 2; protein phosphorylation; signal transduction; cell regulation; neoplasia; apoptosis;
D O I
10.1242/jcs.00074
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CK2 is an extremely conserved pleiotropic protein kinase with a growing list of more than 300 substrates, the majority of which are proteins implicated in signal transduction, gene expression and other nuclear functions. The CK2 phosphoacceptor sites are specified by multiple acidic residues, with the one at position +3 relative to the target residue being of crucial relevance. The CK2 holoenzyme is composed of two catalytic subunits (alphaalpha, alpha'alpha' or alphaalpha'), which are essential for cell viability, and a dimer of two non-catalytic beta subunits, whose precise function is still poorly understood. Although the beta subunits deeply affect many properties of CK2, both the isolated catalytic subunits and the holoenzyme are constitutively active, which is probably responsible for the oncogenic potential of CK2. Given the structure of the holoenzyme, the P subunits could undergo reversible dissociation under physiological conditions and play a role as anchoring elements and/or as a docking platform for protein substrates and effectors. These unusual features are likely to be instrumental in the involvement of CK2 in a number of key biological functions, notably RNA synthesis, Wnt signaling, ubiquitination and cell survival.
引用
收藏
页码:3873 / 3878
页数:6
相关论文
共 50 条
  • [41] Protein kinase CK2 in mammary gland tumorigenesis
    Landesman-Bollag, E
    Romieu-Mourez, R
    Song, DH
    Sonenshein, GE
    Cardiff, RD
    Seldin, DC
    [J]. ONCOGENE, 2001, 20 (25) : 3247 - 3257
  • [42] Protein kinase CK2 inhibition as a pharmacological strategy
    Borgo, Christian
    Ruzzene, Maria
    [J]. ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY, VOL 124: PROTEIN KINASES IN DRUG DISCOVERY, 2021, 124 : 23 - 46
  • [43] Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2
    Gianoncelli, Alessandra
    Cozza, Giorgio
    Orzeszko, Andrzej
    Meggio, Flavio
    Kazimierczuk, Zygmunt
    Pinna, Lorenzo A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7281 - 7289
  • [44] The selectivity of inhibitors of protein kinase CK2: an update
    Pagano, Mario A.
    Bain, Jenny
    Kazimierczuk, Zygmunt
    Sarno, Stefania
    Ruzzene, Maria
    Di Maira, Giovanni
    Elliott, Matthew
    Orzeszko, Andrzej
    Cozza, Giorgio
    Meggio, Flavio
    Pinna, Lorenzo A.
    [J]. BIOCHEMICAL JOURNAL, 2008, 415 (353-365) : 353 - 365
  • [45] Protein kinase CK2 inhibitors: a patent review
    Cozza, Giorgio
    Pinna, Lorenzo A.
    Moro, Stefano
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (09) : 1081 - 1097
  • [46] Validation of protein kinase CK2 as oncological target
    Seeber, S
    Issinger, OG
    Holm, T
    Kristensen, LP
    Guerra, B
    [J]. APOPTOSIS, 2005, 10 (04) : 875 - 885
  • [47] Identification of proteins that associate with protein kinase CK2
    Dongxia Li
    Grazyna Dobrowolska
    Edwin G. Krebs
    [J]. Molecular and Cellular Biochemistry, 1999, 191 : 223 - 228
  • [48] Distinctive features of plant protein kinase CK2
    Marta Riera
    Giovanna Peracchia
    Montserrat Pagès
    [J]. Molecular and Cellular Biochemistry, 2001, 227 : 119 - 127
  • [49] Protein kinase CK2: from structures to insights
    K. Niefind
    J. Raaf
    O.-G. Issinger
    [J]. Cellular and Molecular Life Sciences, 2009, 66 : 3535 - 3536
  • [50] A Journey through the Cytoskeleton with Protein Kinase CK2
    D'Amore, Claudio
    Salizzato, Valentina
    Borgo, Christian
    Cesaro, Luca
    Pinna, Lorenzo A.
    Salvi, Mauro
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (06) : 547 - 562